Advertisement
U.S. Markets close in 1 hr 47 mins

Edesa Biotech, Inc. (EDSA)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
2.6200-0.1200 (-4.38%)
As of 02:05PM EST. Market open.
Advertisement
Show:
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
9/30/2023
9/30/2022
9/30/2021
9/30/2020
Total Revenue
0
0
0
0
328.801
Cost of Revenue
-
-
-
0
17.601
Gross Profit
-
-
-
0
311.2
Operating Expense
7,138
8,642
17,591
13,340
6,712
Operating Income
-7,138
-8,642
-17,591
-13,340
-6,401
Net Non Operating Interest Income Expense
208.952
289.846
63.523
11.165
37.778
Other Income Expense
1.421
-21.742
-21.114
-13.022
-0.366
Pretax Income
-6,928
-8,374
-17,548
-13,342
-6,363
Tax Provision
0.8
0.8
0.8
0.8
0.8
Net Income Common Stockholders
-6,928
-8,374
-17,549
-13,343
-6,364
Diluted NI Available to Com Stockholders
-6,928
-8,374
-17,549
-13,343
-6,364
Basic EPS
-20.51
-20.51
-7.35
-7.70
-5.18
Diluted EPS
-20.51
-20.51
-7.35
-7.70
-5.18
Basic Average Shares
408.418
408.418
2,380
1,725
1,230
Diluted Average Shares
408.418
408.418
2,380
1,725
1,230
Total Operating Income as Reported
-8,380
-9,223
-18,371
-23,681
-6,401
Total Expenses
7,138
8,642
17,591
13,340
6,730
Net Income from Continuing & Discontinued Operation
-6,928
-8,374
-17,549
-13,343
-6,364
Normalized Income
-6,917
-8,361
-17,533
-13,334
-6,364
Interest Income
208.952
289.846
63.523
11.165
37.778
Net Interest Income
208.952
289.846
63.523
11.165
37.778
EBIT
-7,138
-8,642
-17,591
-13,340
-6,401
EBITDA
-6,950
-8,458
-17,472
-13,222
-6,343
Reconciled Cost of Revenue
-
-
-
0
17.601
Reconciled Depreciation
187.813
183.471
118.188
118.788
57.563
Net Income from Continuing Operation Net Minority Interest
-6,928
-8,374
-17,549
-13,343
-6,364
Total Unusual Items Excluding Goodwill
-13.345
-21.742
-21.114
-13.022
-0.366
Total Unusual Items
-13.345
-21.742
-21.114
-13.022
-0.366
Normalized EBITDA
-6,937
-8,437
-17,451
-13,209
-6,343
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-2.0018
-8.6968
-5.534
-3.4508
-0.097